Therapeutic rationale of antidepressant use in the elderly

Archives of Gerontology and Geriatrics

Volumn 44, Issue SUPPL., 2007, Pages 83-90

  Berra, C ^a   Torta, R ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Antidepressants; Psychopharmacotherapy in elderly; Treatment of depression

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DESIPRAMINE; DOPAMINE UPTAKE INHIBITOR; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HISTAMINE H1 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; SEROTONIN 2 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIGMA OPIATE RECEPTOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGED; AGING; ARTICLE; CARDIOTOXICITY; COMORBIDITY; CONSTIPATION; DEPRESSION; DRUG EFFECT; DYSKINESIA; DYSTONIA; ECCHYMOSIS; ELDERLY CARE; EXTRAPYRAMIDAL SYNDROME; GASTROINTESTINAL MOTILITY DISORDER; GERONTOPSYCHIATRY; HEART ARRHYTHMIA; HUMAN; NAUSEA; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PETECHIA; PHARMACODYNAMICS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SEDATION; SIDE EFFECT; SODIUM BLOOD LEVEL; UNSPECIFIED SIDE EFFECT; VASOCONSTRICTION; VASODILATATION; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

AGED; ANTIDEPRESSIVE AGENTS; DECISION MAKING; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL MOTILITY; HALF-LIFE; HEALTH STATUS; HUMANS; INTESTINE, SMALL; PSYCHOLOGY;

EID: 33847056257     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2007.01.012     Document Type: Article

References (25)

1. Alexopoulos G.S. The assessment and treatment of depressed-demented patients. In: Nelson J.C. (Ed). Geriatric Psychopharmacology (1998), Marcel Dekker, New York 223-243
2. Buffum M.D., and Buffum J.C. Treating depression in the elderly: an update on antidepressants. Geriatr. Nurs. 26 (2005) 138-142
3. Bugeja G., Kumar A., and Banerjee A.K. Exclusion of elderly people from clinical research: a descriptive study of published reports. Br. Med. J. 25 (1997) 1059
4. Campion E.W., Avorn J., Reder V.A., and Olins N.J. Overmedication of low-weight elderly. Arch. Int. Med. 147 (1987) 945-947
5. Gareri P., Falconi U., De Fazio P., and De Sarro G. Conventional and new antidepressant drugs in the elderly. Progr. Neurobiol. 61 (2000) 353-396
6. Glassman A.H. Cardiovascular effects of antidepressant drugs. J. Clin. Psychol. 59 Suppl. 15 (1998) 13-18
7. Hoyberg O.J., Maragakis B.K., Mullin J., Norum D., Stordall E., Ekdahl P., Ose E., Moksnes K.M., and Sennef C. A double blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients. Acta Psychiatr. Scand. 93 (1996) 184-190
8. Kasper S., De Swart H., and Friis Andersen H. Escitalopram in the treatment of depressed elderly patients. Am. J. Geriatr. Psychiatry 13 (2005) 884-891
9. Katz I.R., Streim J., and Parmelee P. Prevention of depression, recurrence and complications in late life. Prev. Med. 23 (1994) 743-750
10. Katzman R. Human nervous system. In: Masoro E.J. (Ed). Handbook of Physiology, Sect. 11: Aging (1995), Oxford University Press, New York 325-344
11. Katona C., Bercoff E., Chiu E., Tack P., Versiani M., and Woelk H. Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: A double-blind randomized trial. J. Affect. Disord. 55 (1999) 203-213
12. Klotz U. Effect of age on pharmacokinetics and pharmacodynamics in man. Int. J. Clin. Pharmacol. Ther. 36 (1998) 581-585
13. Koenig H.G., and Blazer D.G. Epidemiology of geriatric affective disorders. Clin. Geriatr. Med. 8 (1992) 235-251
14. Kompoliti K., and Goetz C.G. Neuropharmacology in the elderly. Neurol. Clin. North Am. 16 (1998) 599-610
15. Lebowitz B.D., Pearson J.L., Schneider L.S., Reynolds C.F., Alexopoulos G.S., Bruce M.L., Conwell Y., Katz I.R., Meyers B.S., Morrison M.F., Mossey J., Niederehe G., and Parmelee P. Diagnosis and treatment of depression in late life: consensus statement update. J. Am. Med. Assoc. 278 (1997) 1186-1190
16. Lecrubier Y. Is depression under-recognized and under-treated?. Int. Clin. Psycho-pharmacol. 13 (1998) S1-S2
17. Mahapatra S.N., and Hackett D. A randomized, double-blind, parallel group comparison of venlafaxine and dothiepin in geriatric patients with major depression. Int. J. Clin. Pract. 51 (1997) 209-213
18. Mendlewicz J. Care of depression in older patients. Introduction. Int. Clin. Psychopharmacol. 13 (1998) S1-S2
19. Mühlberg W., and Platt D. Age-dependent changes in the kidneys: pharmacological implications. Gerontology 45 (1999) 243-253
20. Oslin D.W., Ten Have T.R., Streim J.E., Datto C.J., Weintraub D., DiFilippo S., and Katz I.R. Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. J. Clin. Psychiatry 64 (2003) 875-882
21. Salzman C., Wong E., and Cody Wright B. Drug and ECT treatment of depression in the elderly, 1996-2001: A literature review. Biol. Psychiatry 52 (2002) 265-284
22. Steffens D.C., Skogg I., Norton M.C., Hart A.D., Tschanz J.T., Plassman B.L., Wyse B.W., Welsh-Bohmer K.A., and Breitner J.C.S. Prevalence of depression and its treatment in an elderly population: the Cache County study. Arch. Gen. Psychiatry 57 (2000) 601-607
23. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp. Gerontol. 38 (2003) 843-853
24. Vestal R.E. Aging and pharmacology. Cancer 80 (1997) 1302-1310
25. Voltz H.P., and Moeller H.J. Antidepressant drug therapy in the elderly. A critical review of the controlled clinical trials conducted since 1980. Pharmacopsychiatry 27 (1994) 93-100